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Since the  major discovery of Beeson  (1),  numerous reports have established  that 
bacterial  pyrogens  induce  the  production  of a  circulating  mediator  that  can  act 
directly on the fever centers (2, 3). This serum factor, which seems to be identical to 
leukocyte pyrogen (LP), 1 elicits a monophasic fever of short latency and duration  (3), 
probably by stimulating synthesis of derivatives of arachidonic  acid  in  the anterior 
hypothalamic area  (4,  5).  However, some findings have suggested that, besides this 
common effector, bacterial products may also act directly on thermosensitive brain 
structures (5-7). 
N-acetylmuramyl-L-alanyl-D-isoglutamine, or muramyl dipeptide  (MDP),  a  small 
molecular weight (<500) synthetic immunoadjuvant  (8-10), has been shown to have 
a definite pyrogenic effect (11-13), and to elicit LP both in vitro (13) and in vivo (14). 
The fever response was completely abolished  by indomethacin  treatment, although 
the  production  of endogenous  pyrogen  was  not  inhibited. 2 The  present  study was 
designed to determine whether this compound could have a direct effect on the brain 
centers besides its indirect  effect through  the production of LP (13).  In comparison, 
an  adjuvant~inacti~,e  MDP-stereoisomer and  MDP  components were also  adminis- 
tered by the intra~tsternal route. 
Materials and Methods 
Synthetic Compounds.  MDP was MDP-Pasteur (Institut Pasteur Production, Paris).  Its ster- 
eoisomer N-acetylmuramyI-D-alanyl-D-isoglutamine [MDP (D-D)] and the dipeptide (DP), L- 
alanyI-D-isoglutamine, were prepared by Lefraneier et al.  (15) as previously described. The 
MDP sugar moiety N-acetylmuramic acid (AcMur)  was obtained from the same batch used for 
synthesis.  All the solutions were controlled by the Limulus amoebocyte lysate test, performed 
as previously reported (16). MDP and other synthetic compounds were always negative at 100 
#g/ml. 
Rabbit  Pyrogen Assay.  Male New Zealand white rabbits that weighed  between 2 and 3 kg 
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i Abbreviations used  in  this paper:  AcMur, N-acetylmuramic acid; CNS, central  nervous system;  CSF, 
cerebrospinal fluid;  DP, dipeptide; LP, leukocyte  pyrogen; MDP, N-acetylmuramyl-L-alanyl-o-isogluta- 
mine; MDP(D-D), N-acetylmuramyl-D-alanyl-n-isoglutamine;  PBS,  phosphate-buffered saline;  AT(°C), 
changes in temperature expressed as deviation from the baseline recorded at the time of iniection. 
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were used throughout the study. All glassware, needles, syringes and phosphate-buffered saline 
(PBS) were pyrogen free. Rabbits that did not have a stable temperature base line during at 
least the preceding 30 rain were discarded. Rectal temperature was recorded every 15 rain for 
5 h after the injection with thermistor probes connected to a telethermometer (Ellab, Copen- 
hagen). Changes in temperature are expressed  as deviation from the base line recorded at the 
time of injection (AT[°C]). 
Implantation of Cannula into the Cerebral Ventricle.  A  cannula was  implanted  in  an aseptic 
operation into the right cerebral ventricle under pentobarbital anesthesia (25 mg/kg i.v.). The 
cannula  used  and  the  method  of implantation  were essentially  the  same as  described  by 
Feldberg in  1953 (17). Benzyl  penicillin  powder was sprinkled onto the wound, and 2,000 U 
was  administered  subcutaneously  after _the operation.  Animals  were  used  only  8  d  later. 
Injections  (20/~l/kg)  were  made  through  the  rubber diaphragm of the  cap,  with  controls 
receiving  PBS  only.  In  certain  experiments,  collection  of cerebrospinal  fluid  (CSF)  was 
performed by the same route 4 h after intracerebroventricular injection of MDP. 
Passive Transfer of Blood.  Heparinized blood from donors was collected  aseptically from the 
carotid under pentobarbital anesthesia.  Plasma was immediately separated by centrifugation 
in the cold at 2,000 g for 15 rain and dialyzed overnight at 4°C with sterilized  dialysis tubing 
against 200 vol of PBS to eliminate possible residual MDP. On the following day, plasma was 
prewarmed to 37°C before being slowly injected into the recipient rabbit by the intravenous 
route (10 ml/kg). 
Results 
Compared  Pyrogenicity  of  MDP  after Intravenous  or  lntracerebmventricular Adminis- 
tration.  MDP was administered intravenously at  10,  30,  50,  100,  and 300/~g/kg.  A 
good dose-response curve was obtained,  and  the minimal  pyrogenic dose of MDP 
that can induce a rise in temperature of 0.6°C corresponds to 25/~g/kg, as shown by 
the  log  dose-response  line  (Fig.  1).  Typical  fever  patterns  produced  by  a  single 
intravenous injection of 30 or 300 #g of MDP are also depicted in Fig.  1. As is often 
seen with other pyrogens, a biphasic fever was produced with the higher dose, whereas 
the lower dose elicited only a monophasic response (Fig.  1). 
Intracisternal injections of MDP were made at doses varying between  1 and  10  -4 
/xg/kg with  10-fold dilutions.  Again, a  good dose-response curve was obtained with a 
tremendous increase of sensitivity because the minimal pyrogenic dose corresponds to 
0.13 ng/kg (Fig. 2), and, therefore, was ~200,000-fold smaller than by the intravenous 
route. In contrast to Fig.  1, the fever pattern was monophasic at all doses. Moreover, 
at a higher dosage level such as 1 #g/kg (not reported in Fig. 2), temperature remained 
elevated for 24 h  or more, whereas in all other cases it was reversed after 5  or 6  h. 
However,  treatment  with  indomethacin,  which  has  been  shown  to  inhibit  MDP- 
induced fever,  2 completely prevented the rise of temperature elicited by the intracer- 
ebroventricular injection of 1.5  ng/kg of MDP, which corresponded to  10 minimal 
pyrogenic doses. 
Comparison of Endogenous Pyrogen Release in Plasma after Intravenous of lntracerebroventricular 
Administration of MDP (Fig. 3).  Because a previous study has shown us that transfer- 
able  circulating  endogenous  pyrogen  can  be  demonstrated  after  an  intravenous 
injection of MDP (14), similar experiments were performed after intracerebroventric- 
ular  administration.  All  donor  rabbits  uniformly  received  300  ~g  of MDP  either 
intravenously or by intracerebroventricular injection, this dose represents ~ 10 mini- 
mal  pyrogenic  doses  by  the  first  route  and  2  ×  l0  s  doses  by  the  latter.  Controls 
received the same volume of PBS either by intracerebroventricular or by intravenous 
route  (not  reported  in  Fig.  3).  The  temperature of all  donors was recorded  before AT(°C) 
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Fro.  l.  Febrile  response  of the rabbit to intravenous (iv) administration of MDP. Results are given 
as mean 3= SD; number of rabbits are given in parentheses, inj, injection; a, slope; r  2, coefficient of 
correlation. 
bleeding. Blood was collected, in all cases, 2.5 h after intravenous administration, and 
either 2.5 or 5 h after intracerebroventricular injection. Plasma samples were dialyzed 
overnight and injected into untreated recipients on the following day. Fever responses 
were recorded during 3 h. 
As  usual,  plasma  collected  from  donors  that  had  received  MDP  intravenously 
elicited a  monophasic response with a  peak at  1 h, typical of circulating endogenous 
pyrogen. However, all samples collected from donors that had received MDP by the 
intracerebroventricular  route  2.5  or  5  h  previously  were  unable  to  increase  the 
recipients'  temperature,  although  300 #g of MDP  administered  by this  route was 
repeatedly  shown  to  produce  hyperthermia  during  several  days.  Plasma  of PBS- 
treated controls was also negative. 
Absence of Endogenous  Pyrogen in Cerebrospinal Fluid after Intracerebroventricular Administra- 
tion of MDP.  In  experiments  that  will  be  published  separately,  samples  of  the 
pyrogenic supernate obtained from rabbit cells (107/ml)  incubated with MDP were 
injected  either  by  the  intravenous  or by  the  intracerebroventricular  route.  It  was 
observed that  2 #l/kg  induced  a  strong  febrile response by intracerebroventricular 
route,  whereas,  by  the  intravenous  route,  0.5  ml/kg  of  the  same  supernate  was 
required  to  obtain  a  similar  response.  Therefore,  fever  can  also  be  elicited  after 872 
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Fro.  2.  Febrile response to intracerebroventricular  (icy) administration of MDP. Results are given 
as mean -4- S'D; number of rabbits are given in parentheses, inj, injection; a, slope; r 2, coefficient of 
correlation. 
intracisternal injection of MDP-induced endogenous pyrogen. Because circulating LP 
could not  be  detected  in  the  plasma  after intracerebroventricular injection of the 
glycopeptide, the following experiments were performed to find whether MDP could 
produce LP through the cells present in the cerebrospinal fluid. 
Six rabbits received 0.5 #g/kg of MDP by the intracerebroventricular route and 
CSF was collected through the implanted cannulae 4 h later, at time of fever peak. 
Pooled CSF was dialyzed overnight against a large volume (1 liter) of PBS to eliminate 
both  residual  MDP  and  prostaglandins.  On  the  following day,  the  presence  of 
endogenous pyrogen was evaluated in three new recipients by an intracerebroventric- 
ular  injection of 20 #l/kg  of the  dialyzed pool.  No  elevation  of temperature  was 
observed, although minute amounts of LP can be detected by this route. 
Pyrogenicity of an Inactive MDP Stereoisomer and of MDP Components after lntracerebroven- 
tricular Injection.  The adjuvant-inactive stereoisomer, MDP(D-D),  which is not py- ATPC 
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Fro.  3.  Passive transfer experiments of plasma from rabbits made febrile by intravenous (iv)  or 
intracerebroventricular (icy)  injection of MDP. Results are given as mean "4- SD for three rabbits 
per group, donors or recipients, inj, injection. 
rogenic after intravenous administration of 10 mg/kg, was injected intraventricularly 
at  doses  varying between  100  and  0.1  #g/kg with  10-fold dilutions.  A  good  dose- 
response curve was obtained with a monophasic fever pattern (Fig. 4), although the 
stereoisomer was  ~20,000-fold less  pyrogenic than MDP administered by the same 
route. Moreover, one cannot completely exclude some contamination by MDP during 
the preparation of its stereoisomer. 
MDP contains a sugar moiety, AcMur, and a  DP, L-alanyl-D-isoglutamine. These 
components were administered together or separately by the intracerebroventricular 
route. As shown in Fig. 5, even when high dosages (50 or  100 #g) of DP or AcMur 
were administered, separately or together, no fever was observed in contrast to the 
strong elevation induced by 0.01 #g/kg of MDP. 874  PYROGENICITY  OF  A  SYNTHETIC  ADJUVANT 
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Fro.  5.  Absence of pyrogenicity of MDP  moieties administered by the  intracerebroventricular 
route. Results are given as mean +  SD of three rabbits per group, inj, injection. 
Discussion 
The  findings  reported  here  demonstrate  that  the  intracerebroventricular  route 
potentiates  tremendously  (~200,000-fold)  the  pyrogenicity  of  MDP.  Under  such RIVEAU, MA~IEK, PARANT, AND CHEDID  875 
conditions, a strong and lasting febrile response was elicited, although no circulating 
endogenous pyrogen could be detected in the plasma or in the CSF. 
It has previously been shown that by the intravenous route, both amino acids are 
required to induce a febrile response to MDP because AcMur-L-alanine and AcMur- 
D-isoglutamine were inactive (18). The present study, performed by the much more 
sensitive intracerebral route, confirms that MDP represents the minimal requirement 
for inducing the febrile response ascribed to bacterial peptidoglycan (11,  12). Thus, 
neither the DP nor the sugar moiety injected together or separately at a  dosage  106- 
fold greater than MDP, elicited any rise of rabbit  temperature. It must be recalled 
that the MDP components, and the MDP stereoisomer used in this study as well, are 
devoid  of immunostimulant  properties  (!0,  16).  Yet,  after intracerebroventricular 
injection,  MDP(D-D)  induced  a  febrile response,  but  at  dosage  levels  10,000-fold 
higher than for MDP. All preparations were controlled by the Limulus amoebocyte 
lysate test to rule out the presence of endotoxic contamination. Absolute proof of an 
intrinsic pyrogenicity of the stereoisomer is lacking, however, because a minor amount 
of MDP cannot be totally excluded. 
The  extraordinary effectiveness of this  small  molecular  weight  glycopeptide in 
inducing fever after an intracerebroventricular injection raises again the question of 
the  role  of endogenous  pyrogen  in  the  mechanism  of fever  production  (4).  The 
requirement of LP release to produce fever can be bypassed because a febrile response 
can be directly elicited by intracerebroventricular administration of  bacterial pyrogens 
such as gram-negative lipopolysaccharide (7), or streptococcal peptidoglycan (12, 19) 
and exotoxin (20). However, more recent studies have confirmed a previous evidence 
that  lipopolysaccharide  does  not  cross  the  blood-brain  barrier  (21).  Endogenous 
pyrogen can also produce fever when  injected by the intracerebroventrieular route 
(22), but evidence for circulating LP entering the central nervous system  (CNS)  is 
also  lacking  (4).  Such  studies  have  not  yet  been  performed with  other  pyrogens. 
Because of its small molecular weight, and although it is cleared very rapidly (23), the 
synthetic glycopeptide could more readily have access to the thermoregulating centers. 
Moreover, preliminary experiments have shown us that in rabbits made leukopenic 
by nitrogen mustard treatment, intravenous injection of MDP could produce fever in 
the  absence  of circulating  plasma  endogenous  pyrogen.  Such  a  dissociation  was 
confirmed by intracisternal administration, which resulted in high fever without the 
production of endogenous pyrogen in the plasma or in the CSF.  Similarly, Harvey 
and  Milton  (22)  have  previously  found  that  central  administration  of endotoxin 
produces fever without activating the release of peripheral endogenous pyrogen. This 
does  not  exclude  the  possibility  that  centrally  produced  prostaglandins  may  be 
involved in the febrile response because they may enter the CNS through the cerebral 
circulation  in  amounts  sufficient  to  produce  fever  (21).  Moreover,  responses  to 
centrally administered pyrogens can be inhibited by antipyretic drugs, which block 
the  prostaglandin  system  synthesis  (4).  The  data  reported  here  also  show  that 
indomethacin can abolish fever produced by intracisternal administration Of MDP. 
In summary, our present study strongly suggests that MDP can be pyrogenic by a 
direct effect on brain structures that control the body temperature. It is noteworthy 
to  recall  that  even  in  the  ease  of large  molecular weight  lipopolysaccharide,  the 
possibility that toxin fragments could penetrate and act directly on CNS thermosen- 
sitive structures has never been completely ruled out. 876  PYROGENICITY OF  A SYNTHETIC ADJUVANT 
Summary 
Fever can be elicited in the rabbit by the intravenous administration of relatively 
large  doses  of a  synthetic  immunoadjuvant,  N-acetylmuramyl-L-alanyl-D-isogluta- 
mine, or muramyl dipeptide (MDP). This response could be mediated by endogenous 
pyrogen because MDP has been shown to induce their production both in vivo and 
in vitro. The results reported here show that intracisternal injection of minute amounts 
of MDP could elevate fever without activating the release of endogenous pyrogen in 
the plasma or in  the cerebrospinal  fluid.  Moreover, indomethacin  inhibited  hyper- 
thermia produced by intracerebroventricular administration of MDP. Therefore, our 
findings argue in favor of a direct effect of the glycopeptide on the thermoregulatory 
centers besides its indirect effect through the production of leukocytic pyrogen. This 
molecule  apparently  represents  the  minimal  requirement  for  the  pyrogenicity  of 
bacterial peptidoglycan because administration, even by the intracerebral route, of a 
mixture of muramic acid and of its dipeptide moiety did not elicit fever. 
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